Array comparative genomic hybridization-based characterization of genetic alterations in pulmonary neuroendocrine tumors.
about
Is the Canonical RAF/MEK/ERK Signaling Pathway a Therapeutic Target in SCLC?Small cell lung cancer (SCLC): no treatment advances in recent yearsFGFR1 is an adverse outcome indicator for luminal A breast cancers.Immune checkpoint blockade in small cell lung cancer: is there a light at the end of the tunnel?Pharmacogenomic approach to identify drug sensitivity in small-cell lung cancerSurvival and Predictors of Death for Patients with Bronchopulmonary Carcinoid at a Danish Tertiary NET Centre.A novel approach to DNA copy number data segmentation.Therapeutic priority of the PI3K/AKT/mTOR pathway in small cell lung cancers as revealed by a comprehensive genomic analysis.Genomic profiling by whole-genome single nucleotide polymorphism arrays in Wilms tumor and association with relapse.Small cell lung cancer: therapies and targetsGenetic characterization of large parathyroid adenomasTargeting transcriptional addictions in small cell lung cancer with a covalent CDK7 inhibitorGlobal microRNA profiling of well-differentiated small intestinal neuroendocrine tumors.Delta-like 1 homolog (dlk1): a marker for rhabdomyosarcomas implicated in skeletal muscle regeneration.Role and relevance of TrkB mutations and expression in non-small cell lung cancer.Nuclear factor I/B is an oncogene in small cell lung cancerDeletions of 11q22.3-q25 are associated with atypical lung carcinoids and poor clinical outcome.The effect of PTEN on serotonin synthesis and secretion from the carcinoid cell line BONTreatment of liver metastases in patients with neuroendocrine tumors: a comprehensive review.Loss of 18q22.3 involving the carboxypeptidase of glutamate-like gene is associated with poor prognosis in resected pancreatic cancer.Typical bronchial carcinoid metastasizing to the brain: a case presentation.A crucial requirement for Hedgehog signaling in small cell lung cancerNovel therapeutic approaches for small cell lung cancer: the future has arrivedA framework for identification of actionable cancer genome dependencies in small cell lung cancer.Bromodomain and hedgehog pathway targets in small cell lung cancer.Genome-wide identification of genes with amplification and/or fusion in small cell lung cancerElevated expression of SOX2 and FGFR1 in correlation with poor prognosis in patients with small cell lung cancer.The Janus kinases inhibitor AZD1480 attenuates growth of small cell lung cancers in vitro and in vivo.Wentilactone A as a novel potential antitumor agent induces apoptosis and G2/M arrest of human lung carcinoma cells, and is mediated by HRas-GTP accumulation to excessively activate the Ras/Raf/ERK/p53-p21 pathway.Rs2853677 modulates Snail1 binding to the TERT enhancer and affects lung adenocarcinoma susceptibility.Cotargeting the PI3K and RAS pathways for the treatment of neuroendocrine tumorsThe molecular pathogenesis and management of bronchial carcinoids.Novel strategies for the treatment of small-cell lung carcinoma.Fibroblast growth factors and their receptors in cancer.The Biological Role of PI3K Pathway in Lung Cancer.Integrative genome analyses identify key somatic driver mutations of small-cell lung cancerOptimal drugs for second-line treatment of patients with small-cell lung cancer.Barasertib (AZD1152), a Small Molecule Aurora B Inhibitor, Inhibits the Growth of SCLC Cell Lines In Vitro and In Vivo.Therapies in the pipeline for small-cell lung cancer.Emerging trends in the evaluation and management of small cell prostate cancer: a clinical and molecular perspective.
P2860
Q26748741-3B4AF4F6-B402-45F7-AB6C-A391C1990025Q26767020-B7DD4D96-DAB0-4D34-B9A2-2E540617CD1DQ27853294-A2F29081-8A55-4F06-BD01-13F5A1555F8AQ28079771-6ED1F500-A387-4597-955E-6EA92082F231Q28542859-DE2E5769-F6DF-4B96-AA85-B1882710FFC2Q33770786-93F69621-FF8B-4341-A6D7-63A3AB5445D1Q33822782-95B197D8-64F7-44F9-ABE5-E8C1987AFD20Q34134584-EB85268C-333C-41BC-A951-AB66A8FAE243Q34190897-544F6B56-9DED-4804-8121-8B1A5A4FB8CAQ34250859-F678ED1D-E470-41B2-A508-1727082AFAEFQ34264055-09749987-5599-479E-AADF-D8814636DC15Q34452854-713BD320-9FB6-4F39-B402-8924ED08BF86Q34553261-24754BE5-F99A-4593-927C-7877F414D095Q34663937-5FDB265C-8322-4B41-A032-13F50F288708Q34917434-9ABEA018-3BCE-4E8C-93A6-9EE4604021A4Q35128800-CC0F6628-1093-404B-BDA9-082DCC57B401Q35167949-84924484-D2A6-4CDC-9A29-AB3E6FEFFC89Q35178600-5328DC88-7020-4A94-9959-A96031092967Q35371197-D76B943D-D194-427C-BE07-DE3F0D4BAF2CQ35680802-96FAF0C2-6CBD-4132-988A-057DE104F75CQ35710713-7166040F-86FA-401A-A208-2C33DFD746DEQ36050816-0D914D2B-A374-43B2-924E-E57D311AAA71Q36084288-CF579BD2-3CE1-48A3-91D4-315DEB359AE9Q36342432-F8FB41A1-CBC1-4FDC-A1A3-5CEFBF178893Q36535682-1EAF3B0A-A31E-49DF-A895-E69585C5330DQ37250224-345EC1A0-97E1-4372-95AD-6CD3BA25894AQ37349481-0AAE0155-BA4C-4B8C-B5FE-947DA932E4F3Q37412314-C45CF738-BF05-4DA3-B25A-249EE973C87CQ37424084-9E7DAB69-3CAF-46F2-B10C-5E447049FC29Q37437316-A55B050C-4044-4E36-ACBC-1B178D7BC80DQ37626626-A597D5D6-BE3B-4D11-BF0A-C4F18C3298A4Q37833109-5986C188-22AA-45D1-A4E5-DC5D5A03117EQ37892341-9911622A-C315-4AD3-8300-4D994AB20D0CQ37895306-2699492E-881D-42B7-B209-C606F5CA6FBCQ38166599-771D165D-1E85-4A06-9720-0513F8DAFFACQ38322114-1D3D1244-B935-4A97-8652-4C116F63579AQ38734204-416A0E6D-A0C2-4BE6-A693-1304554CCF91Q38753586-FD22C3C2-FE66-4DEB-9701-CDC0C811E2C8Q38871386-5557B084-2F4B-4474-B5CA-57E6CAA99F53Q38930155-B38B014D-271A-4681-8EE2-8D989B548870
P2860
Array comparative genomic hybridization-based characterization of genetic alterations in pulmonary neuroendocrine tumors.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Array comparative genomic hybr ...... lmonary neuroendocrine tumors.
@ast
Array comparative genomic hybr ...... lmonary neuroendocrine tumors.
@en
Array comparative genomic hybr ...... lmonary neuroendocrine tumors.
@nl
type
label
Array comparative genomic hybr ...... lmonary neuroendocrine tumors.
@ast
Array comparative genomic hybr ...... lmonary neuroendocrine tumors.
@en
Array comparative genomic hybr ...... lmonary neuroendocrine tumors.
@nl
prefLabel
Array comparative genomic hybr ...... lmonary neuroendocrine tumors.
@ast
Array comparative genomic hybr ...... lmonary neuroendocrine tumors.
@en
Array comparative genomic hybr ...... lmonary neuroendocrine tumors.
@nl
P2093
P2860
P356
P1476
Array comparative genomic hybr ...... ulmonary neuroendocrine tumors
@en
P2093
Jih-Hsiang Lee
Johannes Voortman
Jonathan Keith Killian
Miia Suuriniemi
Paul Meltzer
William I Smith
Yisong Wang
Yonghong Wang
P2860
P304
13040-13045
P356
10.1073/PNAS.1008132107
P407
P577
2010-07-06T00:00:00Z